- Patent Title: Drug implants containing enzalutamide and methods of use thereof
-
Application No.: US17728702Application Date: 2022-04-25
-
Publication No.: US11666528B2Publication Date: 2023-06-06
- Inventor: Maithili Rairkar , Pujan Desai , Carlos Schuler , Keith Hall , Pamela Munster , John Maroney , Scott Thomas
- Applicant: The Regents of the University of California , Alessa Therapeutics, inc.
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California,Alessa Therapeutics, Inc.
- Current Assignee: The Regents of the University of California,Alessa Therapeutics, Inc.
- Current Assignee Address: US CA Oakland; US CA San Carlos
- Agency: Bozicevic, Field & Francis LLP
- Agent Edward J. Baba
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K47/34 ; A61K31/4166
Abstract:
Provided herein are drug implants comprising enzalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and enzalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
Public/Granted literature
- US20230080240A1 DRUG IMPLANTS CONTAINING ENZALUTAMIDE AND METHODS OF USE THEREOF Public/Granted day:2023-03-16
Information query
